The BioStar OIA RSV test features a dual-detection technology to provide additional confidence in your results. Approved for children under age 5 with a simple, easy-to-use procedure that provides an answer in just over 15 minutes.

This combination of performance and ease-of-use will enable you to decrease costs for unnecessary ancillary testing, improve appropriate treatment, and decrease patient wait times.

Easy to Use

No additional equipment required

Multiple Specimen Types

Nasal wash and nasopharyngeal (NP) swab.

Further Benefits of the BioStar OIA RSV Test

• Reduce cost by eliminating unnecessary ancillary diagnostics
• Allow physician to prescribe appropriate antiviral medication
• Avoid unnecessary use of antibiotics

Data

An evaluation of a prototype RSV OIA assay for the detection of Respiratory Syncytial Virus was conducted in 2002 at several sites. At these clinical sites, nasal wash samples from symptomatic patients presenting to the pediatric emergency room for care were enrolled in the study.

Sensitivity: 88.50% / Specificity: 97.03%

About RSV

Respiratory Syncytial Virus (RSV) infection, which manifests primarily as bronchiolitis and/or viral pneumonia, is the major respiratory pathogen of young children and the leading cause of lower respiratory disease in infants. The illness is typically characterized by cough, runny nose, wheezing, low-grade fever (<101°F), and decreased oral intake.

In select groups of high-risk patients, appreciable mortality with increased morbidity may occur from this infection. Infants with chronic lung disease of infancy, congenital heart disease, or marked prematurity when hospitalized for this disease may have up to a 3-5% mortality rates.

Bibliography & References

- Hendrickson, K.J. Viral Pneumonia in Children. Seminars in Pediatric Infectious Diseases. 1998. 9(3): 217-233.

- Shay, D.K. et al. Bronchiolitis-Associated Hospitalizations Among US Children, 1980-1996. JAMA. 1999. 282(15): 1440-1446.

- Falsey, A.R. Respiratory Syncytial Virus Infection in Adults. ClinicalMicrobiology Reviews. 2000. 13(3): 371-384.

- Dowell, S.F. et al. Respiratory Syncytial Virus Is an Important Cause of Community-Acquired Lower Respiratory Infection among Hospitalized Adults.J. of Infectious Diseases. 1993. 174: 456-462.

- Gonzales, R. et.al. Antibiotic Prescribing for Adults With Colds, Upper Respiratory Tract Infections, and Bronchitis by Ambulatory CarePhysicians. JAMA. 1997. 278: 901-904.

- Gilchrist, S. National Surveillance for Respiratory Syncytial Virus,United States, 1985-1990. J. of Infectious Diseases. 1994. 170: 986-990.

- Mandell, D. et. al. Principles and Practice of Infectious Disease, Fourth Edition. Churchill Livingstone Inc. 1995. 1501-1519.

- Information provided by eMedicine Journal, Leonard R. Krilov, MD, Chief of Pediatric Infectious Diseases, Department of Pediatrics, Winthrop University Hospital